These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 12390175)
1. A case of intraocular haemorrhage secondary to thrombolytic therapy. Berry C; Weir C; Hammer H Acta Ophthalmol Scand; 2002 Oct; 80(5):561-2. PubMed ID: 12390175 [No Abstract] [Full Text] [Related]
2. Bilateral vitreous hemorrhages as a consequence of thrombolytic therapy successfully treated with vitrectomy in a patient without diabetes. Grekos ZG; Schocken DD Am Heart J; 1995 Sep; 130(3 Pt 1):611-2. PubMed ID: 7661080 [No Abstract] [Full Text] [Related]
3. Intraocular haemorrhage after thrombolysis. Kaba RA; Cox D; Lewis A; Bloom P; Dubrey S Lancet; 2005 Jan 22-28; 365(9456):330. PubMed ID: 15664229 [No Abstract] [Full Text] [Related]
4. Retro-orbital hemorrhage after thrombolysis for acute myocardial infarction. Cunneen TS; Morlet N N Engl J Med; 2007 Oct; 357(14):1448-9. PubMed ID: 17914052 [No Abstract] [Full Text] [Related]
5. Intraocular hemorrhage after systemic thrombolytic therapy in a patient with exudative macular degeneration. Djalilian AR; Cantrill HC; Samuelson TW Eur J Ophthalmol; 2003; 13(1):96-8. PubMed ID: 12635684 [TBL] [Abstract][Full Text] [Related]
6. Postoperative orbital hemorrhage following thrombolysis for acute myocardial infarction. Yuen VH; Dolman PJ Can J Ophthalmol; 1999 Feb; 34(1):33-5. PubMed ID: 10088061 [No Abstract] [Full Text] [Related]
7. Spontaneous suprachoroidal hemorrhage secondary to thrombolysis for the treatment of myocardial infarction. Barsam A; Heatley CJ; Herbert L Clin Exp Ophthalmol; 2006 Mar; 34(2):177-9. PubMed ID: 16626438 [TBL] [Abstract][Full Text] [Related]
8. Neck hematoma after intravenous thrombolysis for stroke treatment. Fonseca AC; Geraldes R; Reimão S; Pinho e Melo T; Ferro JM Cerebrovasc Dis; 2010; 30(1):101-2. PubMed ID: 20501994 [No Abstract] [Full Text] [Related]
9. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis]. Motomiya T Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012 [No Abstract] [Full Text] [Related]
10. [Ischemic ictus during thrombolytic treatment in acute myocardial infarct]. Seijo-Martínez M; Pais A; Castro del Río M; Silva-Martínez M Rev Neurol; 2000 Oct 16-31; 31(8):798-9. PubMed ID: 11082894 [No Abstract] [Full Text] [Related]
11. [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator]. García-Jiménez A; Iriarte Sotés P; Fernández González CJ; Garrote Freire A; González Tutor J An Med Interna; 2003 Mar; 20(3):163-4. PubMed ID: 12756909 [No Abstract] [Full Text] [Related]
12. Splenic rupture: an additional complication of thrombolytic therapy. Summers JB Crit Care Nurse; 2002 Oct; 22(5):18-9; author reply 19-20. PubMed ID: 12382613 [No Abstract] [Full Text] [Related]
13. Early diagnosis of colonic carcinoma: a haemorrhagic complication after the use of tissue plasminogen activator. Baker JW; Mitchell SJ; Dixon AR Postgrad Med J; 2002 Jul; 78(921):429. PubMed ID: 12151663 [TBL] [Abstract][Full Text] [Related]
14. Vitreous hemorrhage after intravitreal tissue plasminogen activator (t-PA) and pneumatic displacement of submacular hemorrhage. Kokame GT Am J Ophthalmol; 2000 Apr; 129(4):546-7. PubMed ID: 10764874 [TBL] [Abstract][Full Text] [Related]